Datar Cancer Genetics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Nashik, MH India
Total Funding:N/A
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

Estimated Revenue & Financials

  • Datar Cancer Genetics's estimated annual revenue is currently $8.8M per year.
  • Datar Cancer Genetics's estimated revenue per employee is $155,000

Employee Data

  • Datar Cancer Genetics has 57 Employees.
  • Datar Cancer Genetics grew their employee count by 36% last year.
  • Datar Cancer Genetics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Datar Cancer Ge...
$8.8M5736%N/A
Roche Diagnosti...
$13.6M8819%N/A
Kan biosys
$8.4M5426%N/A
Missing a competitor? Contribute!?
Submit

Datar Cancer Genetics Limited is engaged in providing customized Oncology solutions for Cancer patients based on molecular analysis of tissue / blood based genetic profiles. Our Centre of Excellence meets and exceeds global standards and our research team is at the forefront of cutting edge Molecular Oncology.   Our fully equipped analytical facility is spread over more than 40,000 sq. ft. with the most updated NGS and digital PCR platforms. Our services are NABL accredited.

keywords:N/A

57

Number of Employees

$8.8M

Revenue (est)

1

Current Jobs

36%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Datar Cancer Genetics News

07/16/2019 - Datar Cancer Genetics launches operations in Germany

Datar Cancer Genetics (Europe) GmbH has set up its operations in Germany. It will advance access to Datar Cancer Genetics Ltd's (DCGL) ...

01/12/2018 - Datar Cancer Genetics limited is now CAP accredited

Datar Cancer Genetics Limited, a leading molecular and genetic analysis company has been awarded accreditation by the Accreditation ...

10/12/2017 - Datar Cancer Genetics launches breakthrough blood test for ...

Early detection of cancer has been the Holy Grail for scientists all over the world. Late stage detection is one of the primary reasons for death in ...